Can Calcium and Magnesium Infusion before and after Oxaliplatin Administration Improves Its Neurotoxic Effect?
Journal Title: Journal of Cancer and Tumor International - Year 2017, Vol 6, Issue 1
Abstract
Introduction: The oxaliplatin neurotoxicity is one of two distinct phases: an acute and a dose-limiting cumulative phase. Large doses of I.V Ca & Mg is given before and after oxaliplatin in FOLFOX protocol. Aim: We aimed to evaluate the efficacy of Ca & Mg in improving or eliminating oxaliplatin-induced neurotoxicity. Study Design: Randomized double controlled placebo study. Place and Duration of Study: Clinical Oncology department at Mansoura university hospital, Egypt at the period from July 2014 up to December 2016 inclusive. Methodology: In our study, 140 Patients with adenocarcinoma of the colon received 6 months of FOLFOX protocol. Patients were choiced to receive I.V calcium gluconate plus magnesium sulfate (1 g for both of them) in 100 mL of D5W for about 30 minutes immediately before and after each cycle of oxaliplatin (70 patients ), or an identical looking placebo shortly before and after each cycle of oxaliplatin (70 patients ) in a random manner. The primary end point was a comparison between neurotoxicity assessed by Common Terminology Criteria for Adverse Effects (CTCAE) version 4.0 in both groups. Results: There was statistically significant difference as regard grade of neuralgia. Grade II neuralgia is higher in the study group II (45.7%) compared to (22.9%) in the study group I. There was statistically significant difference as regard grade of paresthesia. Grade II & III are higher in study group II (51.4%, 14.3%) compared to (30.0%, 4.3%) in study group I. Conclusion: Ca and Mg administration with oxaliplatin have been well tolerated. Our results support the role of Ca & Mg in decreasing neurotoxicity associated with oxaliplatin.
Authors and Affiliations
Mohamed S. Zahi, Hend M. Hamdey Rashed Elkalla
Keywords
Related Articles
- EP ID EP309198
- DOI 10.9734/JCTI/2017/35988
- Views 101
- Downloads 0
Aggressive Recurrent Giant Cell Tumour of Distal Ulna with Pulmonary Metastasis: A Case Report
Pulmonary metastasis rarely originates from a benign tumour, but may occur from giant-cell tumours of bone (GCT). It occurs most frequently in recurrent cases and may result in poor outcomes. We report a case with pulmon...
The Pathological Stage at Diagnosis of Breast Cancer in Ghanaian Women: A Retrospective Study at the Korle-Bu Teaching Hospital Accra (2001 to 2014)
Background: Published data on breast cancer (BC) in Ghanaian women have not look at the relationships between pathological stage at diagnosis and the other clinico-pathological features. The aim of this study was to desc...
Alkaline Phosphatase and Simple Gray Scale Ultrasonography in Detecting Liver Metastasis in Breast Cancer Patients: A Comparison between Bone Scan Positive and Bone Scan Negative Patients
Alkaline Phosphatase (s-ALP) has been extensively used to monitor the disease and screen the patients for cancer metastasis. Both the baseline s-ALP and changes in s-ALP have been reported as prognostic factors for treat...
Nutritional Status of Lung Cancer Patients in Benghazi City of Libya
Lung cancer is one of the most common type of cancer in the world and Libya is no exception. Nutrition intervention is often needed for nutrition-related complications of cancer treatment, which include but are not limit...
The Silver, Cobalt, Chromium, Iron, Mercury, Rubidium, Antimony, Selenium and Zinc Contents in Human Bone Affected by Ewing's Sarcoma
Aims: To clarify the role of trace elements in the etiology and the pathogenesis of the Ewing's sarcoma, a non-destructive neutron activation analysis with high resolution spectrometry of long-lived radionuclides were pe...